Invesco Ltd. raised its stake in Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) by 345.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 340,585 shares of the energy company’s stock after acquiring an additional 264,142 shares during the quarter. Invesco Ltd. owned about 1.79% of Hydrogenics worth $5,058,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Ancora Advisors LLC bought a new position in Hydrogenics in the 2nd quarter valued at about $297,000. Gamco Investors INC. ET AL bought a new position in Hydrogenics in the 2nd quarter valued at about $309,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in Hydrogenics in the 2nd quarter valued at about $325,000. Cetera Advisor Networks LLC bought a new position in Hydrogenics in the 2nd quarter valued at about $318,000. Finally, SG Americas Securities LLC bought a new position in Hydrogenics in the 2nd quarter valued at about $764,000. 10.44% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts have weighed in on the stock. Roth Capital increased their price target on shares of Hydrogenics from $8.50 to $15.00 and gave the company a “neutral” rating in a report on Monday, July 1st. Zacks Investment Research cut shares of Hydrogenics from a “hold” rating to a “sell” rating in a report on Thursday, August 15th. Craig Hallum cut shares of Hydrogenics from a “buy” rating to a “hold” rating in a report on Friday, June 28th. BidaskClub cut shares of Hydrogenics from a “buy” rating to a “hold” rating in a report on Saturday, September 7th. Finally, HC Wainwright cut shares of Hydrogenics from a “buy” rating to a “neutral” rating in a report on Friday, June 28th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $10.92.
Shares of NASDAQ:HYGS opened at $14.99 on Friday. The company’s 50 day moving average price is $14.99 and its two-hundred day moving average price is $12.39. Hydrogenics Co. has a 12-month low of $3.80 and a 12-month high of $16.50. The firm has a market cap of $285.11 million, a PE ratio of -17.43 and a beta of 0.66.
Hydrogenics (NASDAQ:HYGS) (TSE:HYG) last announced its earnings results on Monday, August 12th. The energy company reported ($0.25) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.13). Hydrogenics had a negative return on equity of 71.70% and a negative net margin of 38.16%. The business had revenue of $10.46 million for the quarter, compared to analyst estimates of $10.50 million. Analysts forecast that Hydrogenics Co. will post -0.46 earnings per share for the current fiscal year.
Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane (PEM) technology. It operates through two segments, OnSite Generation and Power Systems.
Further Reading: How Do I Invest in Dividend Stocks
Receive News & Ratings for Hydrogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics and related companies with MarketBeat.com's FREE daily email newsletter.